• Management of pain after childbirth Vol 740 • July, 2018.
To content

Management of pain after childbirth Vol 740 • July, 2018.

HEALTH OF WOMAN. 2018.6(132):134–139

Abridged version. Adapted – S.A. Shurpyak

 

REFERENCES

1. Eisenach JC, Pan PH, Smiley R, Lavand’homme P, Landau R, Houle TT. 2008. Severity of acute pain after childbirth, but not type of delivery, predicts persistent pain and postpartum depression. Pain 140:87–94.

2. Bateman BT, Franklin JM, Bykov K, Avorn J, Shrank WH, Brennan TA et al. 2016. Persistent opioid use following cesarean delivery: patterns and predictors among opioid-naive women. Am J Obstet Gynecol 215:353.e1–18. 


3. Centers for Disease Control and Prevention. Breastfeeding report card progressing toward national breastfeeding goals. United States. 2016. Atlanta (GA), CDC. 2016. Available at: https://www.cdc.gov/breastfeeding/pdf/2016breast feedingreportcard.pdf. Retrieved March 9, 2018. 


4. World Health Organization. Cancer pain relief. Geneva, WHO. 1986. Available at: http://apps.who.int/iris/bitstream/ handle/10665/43944/9241561009_eng.pdf. Retrieved March 26, 2018. 


5. Leung L. 2012. From ladder to platform: a new concept for pain management. J Prim Health Care 4:254–8. 6. Carvalho B, Butwick AJ. 2017. Postcesarean delivery analgesia. Best Pract Res Clin Anaesthesiol 31:69–79.

7. American Society of Anesthesiologists Task Force on Acute Pain Management. Practice guidelines for acute pain man– agement in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management. Anesthesiology 116:248–73. 2012.

8. Corso E, Hind D, Beever D, Fuller G, Wilson MJ, Wrench IJ et al. 2017. Enhanced recovery after elective caesarean: a rapid review of clinical protocols, and an umbrella review of systematic reviews. BMC Pregnancy Childbirth 17:91. 


9. Dennis CL, Jackson K, Watson J. 2014. Interventions for treating painful nipples among breastfeeding women. Cochrane Database of Systematic Reviews Issue 12. Art. No.: CD007366. 


10. Vieira F, Mota DD, Castral TC, Guimaraes JV, Salge AK, Bachion MM. 2017. Effects of anhydrous lanolin versus breast milk combined with a breast shell for the treatment of nipple trauma and pain during breastfeeding: a randomized clinical trial. J Midwifery Womens Health 62:572–9. 


11. Berens P, Eglash A, Malloy M, Steube AM. 2016. ABM clinical protocol  26: persistent pain with breastfeeding. Academy of Breastfeeding Medicine. Breastfeed Med 11:46–53. 


12. Fahey JO. 2017. Best practices in management of postpartum pain. J Perinat Neonatal Nurs 31:126–36. 


13. Deussen AR, Ashwood P, Martis R. 2011.  Analgesia for relief of pain due to uterine cramping/involution after birth. 
Cochrane Database of Systematic Reviews  Issue 5. Art. No.: CD004908.

14. Hedayati H, Parsons J, Crowther CA. 2005. Topically applied anaesthetics for treating perineal pain after childbirth. Cochrane Database of Systematic Reviews  Issue 2. Art. No.: CD004223.

15. East CE, Begg L, Henshall NE, Marchant PR, Wallace K. 2012. Local cooling for relieving pain from perineal trauma sus– tained during childbirth. Cochrane Database of Systematic Reviews  Issue 5. Art. No.: CD006304.

16. Mounsey AL, Halladay J, Sadiq TS. 2011. Hemorrhoids. Am Fam Physician 84:204–10.

17. Chou D, Abalos E, Gyte GM, Gülmezoglu AM. 2013. Paraceta–mol/acetaminophen (single administration) for perineal pain in the early postpartum period. Cochrane Database of Systematic Reviews  Issue 1. Art. No.: CD008407.

18. Wuytack F, Smith V, Cleary BJ. 2016. Oral non-steroidal anti– inflammatory drugs (single dose) for perineal pain in the early postpartum period. Cochrane Database of Systematic Reviews  Issue 7. Art. No.: CD011352.

19. Khan MI, Walsh D, Brito-Dellan N. 2011. Opioid and adjuvant analgesics: compared and contrasted. Am J Hosp Palliat Care 28:378–83.

20. Laska EM, Sunshine A, Marrero I, Olson N, Siegel C, Mc– Cormick N. 1986. The correlation between blood levels of ibu– profen and clinical analgesic response. Clin Pharmacol Ther 40:1–7.

21. Seymour RA, Ward-Booth P, Kelly PJ. 1996. Evaluation of different doses of soluble ibuprofen and ibuprofen tablets in postoperative dental pain. Br J Oral Maxillofac Surg 34:110–4.

22. Sostres C, Gargallo CJ, Arroyo MT, Lanas A. 2010. Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract. Best Pract Res Clin Gastroenterol 24:121–32.

23. Viteri OA, England JA, Alrais MA, Lash KA, Villegas MI, Ashimi Balogun OA et al. 2017. Association of nonsteroidal antiinflammatory drugs and postpartum hypertension in women with preeclampsia with severe features. Obstet Gynecol 130:830–5.

24. Sutton CD, Carvalho B. 2017. Optimal pain management after cesarean delivery. Anesthesiol Clin 35:107–24.

25. Valentine AR, Carvalho B, Lazo TA, Riley ET. 2015. Scheduled acetaminophen with as-needed opioids compared to as– needed acetaminophen plus opioids for post-cesarean pain management. Int J Obstet Anesth 24:210–6.

26. Cardoso MM, Leite AO, Santos EA, Gozzani JL, Mathias LA. 2013. Effect of dexamethasone on prevention of postopera– tive nausea, vomiting and pain after caesarean section: a randomised, placebo-controlled, double-blind trial. Eur J Anaesthesiol 30:102–5.

27. Davis KM, Esposito MA, Meyer BA. 2006. Oral analgesia compared with intravenous patient-controlled analgesia for pain after cesarean delivery: a randomized controlled trial. Am J Obstet Gynecol 194:967–71.

28. McNicol ED, Ferguson MC, Hudcova J. 2015. Patient controlled opioid analgesia versus non-patient controlled opioid anal– gesia for postoperative pain. Cochrane Database of  Systematic Reviews Issue 6. Art. No.: CD003348.

29. Lavand’homme PM, Roelants F, Waterloos H, De Kock MF. 2007. Postoperative analgesic effects of continuous wound infiltration with diclofenac after elective cesarean delivery. Anesthesiology 106:1220–5. 


30. Eslamian L, Jalili Z, Jamal A, Marsoosi V, Movafegh A. 2012. Transversus abdominis plane block reduces postoperative pain intensity and analgesic consumption in elective cesar ean delivery under general anesthesia. J Anesth 26: 334–8. 


31. Mukhtar K. 2009.  Transversus abdominis plane (TAP) block. New York (NY),The New York School of Regional Anesthesia. Available at: http://www.nysora.com/files/ 2013/pdf/(v12p28-33)TAPBlock.pdf. Retrieved 2018, March 9. 


32. Bateman BT, Cole NM, Maeda A, Burns SM, Houle TT, Huybrechts KF et al. 2017. Patterns of opioid prescription and use after cesarean delivery. Obstet Gynecol 130:29–35. 


33. Osmundson SS, Schornack LA, Grasch JL, Zuckerwise LC, Young JL, Richardson MG. 2017. Postdischarge opioid use after cesarean delivery. Obstet Gynecol 130:36–41. 


34. Prabhu M, McQuaid-Hanson E, Hopp S, Burns SM, Leffert LR, Landau R et al. 2017. A shared decision-making intervention to guide opioid prescribing after cesarean delivery. Obstet Gynecol 130:42–6. 


35. Ilett KF, Kristensen JH. 2005. Drug use and breastfeeding. Expert Opin Drug Saf 4:745–68. 


36. Rigourd V, de Villepin B, Amirouche A, Bruneau A, Seraissol P, Florent A et al. 2014. Ibuprofen concentrations in human mature milk–first data about pharmacokinetics study in breast milk with AOR-10127 «Antalait» study. Ther Drug Monit 36:590–6. 


37. Spigset O, Hagg S. 2000. Analgesics and breast-feeding: safety considerations. Paediatr Drugs 2:223–38. 


38. Sachs HC. 2013. The transfer of drugs and therapeutics into human breast milk: an update on selected topics. Commit– tee on Drugs. Pediatrics 132:e796–809. 


39. Montgomery A, Hale TW. 2012. ABM clinical protocol 15: analgesia and anesthesia for the breastfeeding mother, revised 2012. Academy of Breastfeeding Medicine. Breastfeed Med 7:547–53. 


40. National Library of Medicine. Ibuprofen. In: Drugs and Lactation Database (LactMed). Available at: https://toxnet. nlm.nih.gov/cgi-bin/sis/search2/f?./temp/;uu12jC:1. Retrieved 2018, March 23. 


41. Wischnik A, Manth SM, Lloyd J, Bullingham R, Thompson JS. 1989. The excretion of ketorolac tromethamine into breast milk after multiple oral dosing. Eur J Clin Pharmacol 36:521–4. 


42. National Library of Medicine. Ketorolac. In: Drugs and Lactation Database (LactMed). Bethesda (MD): NLM; 2018. Available at: http://toxnet.nlm.nih.gov/cgi-bin/sis/ search2/r?dbs+lactmed:@term+@DOCNO+153. Retrieved 2018, April 2. 


43. Hendrickson RG, McKeown NJ. 2012. Is maternal opioid use hazardous to breast-fed infants?. Clin Toxicol (Phila) 50:1–14.

44. Kirchheiner J, Schmidt H, Tzvetkov M, Keulen JT, Lotsch J, Roots I et al. 2007. Pharmacokinetics of codeine and its metab– olite morphine in ultra-rapid metabolizers due to CYP2D6 duplication. Pharmacogenomics J 7:257–65.

45. Coller JK, Christrup LL, Somogyi AA. 2009. Role of active metabolites in the use of opioids. Eur J Clin Pharmacol  65:121–39.

46. Cascorbi I. 2003. Pharmacogenetics of cytochrome p4502D6: genetic background and clinical implication. Eur J Clin Invest 33(suppl):17–22.

47. Crews KR, Gaedigk A, Dunnenberger HM, Klein TE, Shen DD, Callaghan JT et al. 2012. Clinical Pharmacogenetics Imple– mentation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotype. Clinical Pharmacogenetics Implementation Consortium. Clin Pharmacol Ther 91:321–6.

48. Koren G, Cairns J, Chitayat D, Gaedigk A, Leeder SJ. 2006. Phar macogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother. Lancet 368:704.

49. U.S. Food and Drug Administration. FDA drug safety communication: FDA restricts use of prescription codeine pain and cough medicines and tramadol pain medicines in children; recommends against use in breastfeeding women. Silver Spring (MD): FDA; 2017. Available at: https://www. fda.gov/Drugs/DrugSafety/ucm549679.htm. Retrieved 2018, March 9.

50. Ingelman-Sundberg M. 2001. Pharmacogenetics: an opportunity for a safer and more efficient pharmacotherapy. J Intern Med 250:186–200.

51. Samer CF, Daali Y, Wagner M, Hopfgartner G, Eap CB, Rebsamen MC et al. 2010. Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safety. Br J Pharmacol 160:919–30.

52. Linares OA, Fudin J, Daly AL, Boston RC. 2015. Individualized hydrocodone therapy based on phenotype, pharmacoge– netics, and pharmacokinetic dosing. Clin J Pain 31:1026–35.

53. Boswell MV, Stauble ME, Loyd GE, Langman L, Ramey– Hartung B, Baumgartner RN et al. 2013. The role of hydromorphone and OPRM1 in postoperative pain relief with hydrocodone. Pain Physician 16:E227–35.

54. National Library of Medicine. Morphine. In: Drugs and Lactation Database (LactMed). Available at: http://toxnet. nlm.nih.gov/cgi-bin/sis/search2/r?dbs+lactmed:@term +@DOCNO+370. Retrieved 2018, March 9.

55. Kelly LE, Chaudhry SA, Rieder MJ, ’t Jong G, Moretti ME, Lausman A et al. 2013. A clinical tool for reducing central ner– vous system depression among neonates exposed to codeine through breast milk. PLoS One 8:e70073.

56. Opioid use and opioid use disorder in pregnancy. Committee Opinion No. 711. American College of Obstetricians and Gynecologists. Obstet Gynecol 130:e81–94. 2017.

57. Gopman S. 2014. Prenatal and postpartum care of women with substance use disorders. Obstet Gynecol Clin North Am 41:213–28. 


58. Jones HE, Deppen K, Hudak ML, Leffert L, McClelland C, Sahin L et al. 2014. Clinical care for opioid-using pregnant and postpartum women: the role of obstetric providers. Am J Obstet Gynecol 210:302–10. 


59. Screening for perinatal depression. Committee Opinion 630. 2015. American College of Obstetricians and Gynecologists. Obstet Gynecol 125:1268–71. 


60. Virginia Department of Health. Pregnancy-associated deaths from drug overdose in Virginia, 1999-2007: a report from the Virginia Maternal Mortality Review Team. Richmond (VA): VDH; 2015. Available at: http://www.vdh. virginia.gov/content/uploads/sites/18/2016/04/Final– Pregnancy-Associated-Deaths-Due-to-Drug-Overdose.pdf. Retrieved 2018, March 9. 


61. Maryland Department of Health and Mental Hygiene. Maryland maternal mortality review 2016 annual report. Baltimore (MD): DHMH; 2016. Available at: http: //health ymaryland.org/wp-content/uploads/2011/05/ MMR_Report_2016_clean-copy_FINAL.pdf. Retrieved 2018, March 9. 


62. American Society of Addiction Medicine. Public policy statement on the use of naloxone for the prevention of opioid overdose deaths. Chevy Chase (MD), ASAM. 2016. Available at: https://www.asam.org/docs/default– source/public-policy-statements/use-of-naloxone-for-the– prevention-of-opioid-overdose-deaths-final.pdf. Retrieved 2018, March 9.

63. Dowell D, Haegerich TM, Chou R. 2016. CDC guideline for prescribing opioids for chronic pain – United States. published erratum appears in MMWR Recomm Rep 65:295. 2016. MMWR Recomm Rep 65(RR-1):1–49. 2016. Available at: https: //www.cdc.gov/mmwr/volumes/65/rr/rr6501e1.htm. Retrieved 2018, March 9. 


64.National Academies of Sciences, Engineering, and Medicine. Pain management and the opioid epidemic. Balancing societal and individual benefits and risks of prescription opioid use. Washington (DC), National Academies Press. 2017.